The international development organization Transaid has joined forced with Medicines for Malaria Venture (MMA) to tackle malaria case management in Zambia.
The two organisations will work to reduce delays in receiving treatment by increasing access to key malaria medicines and strengthening emergency transport systems for patients with severe malaria. Children under the age of five will be the key target group as they are most at risk of contracting the disease, particularly in rural settings where a delay to treatment can be life-threatening.
Transaid’s Chief Executive Caroline Barber commented, “Our consortium is very proud of our achievements in the MAMaZ and MORE MAMaZ programmes. We are so pleased to be working with MMV, we hope to tackle the issue of severe malaria in Serenje and ensure we build sustainable capacity to continue the work once the project has ended.”
Commenting on the new partnership, Dr David Reddy, MMV’s CEO said, “We are delighted to be collaborating with Transaid on this exciting project to help save lives today and in the future. The majority of lives lost to malaria are those of children living far from health services, who simply don’t get the treatment they need in time. By improving access to quality medicine and improving case management, we can help change that.”
